WO1997007811A1 - Utilisation nouvelle de graines de soja - Google Patents
Utilisation nouvelle de graines de soja Download PDFInfo
- Publication number
- WO1997007811A1 WO1997007811A1 PCT/IL1996/000076 IL9600076W WO9707811A1 WO 1997007811 A1 WO1997007811 A1 WO 1997007811A1 IL 9600076 W IL9600076 W IL 9600076W WO 9707811 A1 WO9707811 A1 WO 9707811A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- soy molasses
- soybean
- molasses
- soy
- well
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A21—BAKING; EDIBLE DOUGHS
- A21D—TREATMENT, e.g. PRESERVATION, OF FLOUR OR DOUGH, e.g. BY ADDITION OF MATERIALS; BAKING; BAKERY PRODUCTS; PRESERVATION THEREOF
- A21D2/00—Treatment of flour or dough by adding materials thereto before or during baking
- A21D2/08—Treatment of flour or dough by adding materials thereto before or during baking by adding organic substances
- A21D2/14—Organic oxygen compounds
- A21D2/18—Carbohydrates
- A21D2/181—Sugars or sugar alcohols
-
- A—HUMAN NECESSITIES
- A21—BAKING; EDIBLE DOUGHS
- A21D—TREATMENT, e.g. PRESERVATION, OF FLOUR OR DOUGH, e.g. BY ADDITION OF MATERIALS; BAKING; BAKERY PRODUCTS; PRESERVATION THEREOF
- A21D2/00—Treatment of flour or dough by adding materials thereto before or during baking
- A21D2/08—Treatment of flour or dough by adding materials thereto before or during baking by adding organic substances
- A21D2/36—Vegetable material
- A21D2/362—Leguminous plants
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L11/00—Pulses, i.e. fruits of leguminous plants, for production of food; Products from legumes; Preparation or treatment thereof
- A23L11/05—Mashed or comminuted pulses or legumes; Products made therefrom
- A23L11/07—Soya beans, e.g. oil-extracted soya bean flakes
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/20—Reducing nutritive value; Dietetic products with reduced nutritive value
- A23L33/21—Addition of substantially indigestible substances, e.g. dietary fibres
- A23L33/22—Comminuted fibrous parts of plants, e.g. bagasse or pulp
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
Definitions
- This invention relates to a novel use of soy molasses.
- the soybean contains various minor constituents that were held in the past to be presumably deleterious anti-nutrients. This presumption, however, has been recently refuted and the minor soybean constituents, are now considered to be highly beneficial and essential phytochemicals for the prevention and amelioration of certain diverse and variant pathological conditions. These minor soybean constituents are today carefully thought about as benign and medicating pharmaceutical nutrients labeled as "nutraceuticals”.
- the soybean nutraceuticals are components like the phytoestrogens isoflavones, such as genistein and daidzein; saponins; soy phytosterols; phytates; phospholipids; the low molecular weight protease inhibitor "Birk-Bowman” trypsin and chemotrypsin inhibitor; phenolic acids, et cetera. It is now generally ascertained that the above mentioned phytochemicals of the soybean are very useful nutraceuticals for the prevention and amelioration of pathological conditions in at least such different cases as cancer, osteoporosis, reduction of prostate hypertrophy, reduction of high cholesterol levels, et cetera.
- the benign effects of these soybean phytochemical or nutraceutical components abound in the literature and are reviewed by Messina M. et al. "The Simple Soybean and your Health", Avery Publication Group, Garden City Park, NY. (1994); Mindel E., “Soy Miracle”, Simon and Schuster, NY. (1995), and others.
- the soybean also includes the oligosugars stachyose and raffinose.
- Soy molasses is a low cost material used almost exclusively as an inexpensive animal feed ingredient. Although some endeavors were made to extract and isolate oligosugars from soy molasses, no attempts were ever been made to use soy molasses, because of its composition and unique combination, as such, as a complete composite of the various soybean nutraceuticals, in addition to its oligosugars, to prevent and ameliorate diverse and variant pathological conditions as well as to provide for general well-being.
- the present invention is based on my discovery that soy molasses, being a complete composite of the benign soybean phytochemical nutraceutical components in addition to soybean oligosugars, can thus have a novel use for the purpose of prevention and amelioration of diverse and variant pathological conditions as well as to provide for general well-being, in ways and modes as shall be hereinafter described.
- Soy molasses is produced according to my Israel Patent No. 19168 by an aqueous alcohol extraction of defatted soybean material, such as defatted soybean flakes, with a warm aqueous alcohol, such as aqueous ethanol, aqueous isopropanol or aqueous methanol. Thereafter the alcohol and some of the water, as is desired, are removed by such methods as evaporation, distillation, steam stripping, et cetera, to obtain essentially alcohol free, soy molasses with desired moisture content.
- aqueous alcohol such as aqueous ethanol, aqueous isopropanol or aqueous methanol.
- Soy molasses being a soybean product removed from, practically free of, and undiluted with, the major components of the soybean that are: the storage proteins of the soybean, the soybean oil, the soybean polysaccharides and the soybean fiber material, is thus virtually a concentrated composite source of substantially all the "minor" soybean phytochemical nutraceutical components.
- the soy molasses contains along with the oligosugars stachyose and raffinose, the phytoestrogens isoflavones: genistein and daidzein, and other soybean isoflavones, sapoinns, phytosterols, phytates, the Birk-Bowman trypsin and chemotrypsin inhibitor, phospholipids, and phenolic acids.
- Soy molasses can consequently be considered as an enriched composite source of the recognized soybean constituents that are beneficial for prevention and amelioration of various pathological conditions and thus can therefore, as I discovered, have a novel use, never heretofore contemplated, for prevention and amelioration of diverse and variant pathological conditions as well as to provide for general well-being.
- Another object of the invention is to provide a novel use for soy molasses, being an inexpensive composite source of all the recognized soybean phytochemical nutraceutical constituents, for prevention and amelioration of divers and variant pathological conditions as well as to provide for general well-being.
- Yet another object of the invention is to provide a novel use for soy molasses, for prevention and amelioration of diverse and variant pathological conditions as well as to provide for general well-being, by various means, including the use of the soy molasses, for the object of this invention, as an inert or a functional food ingredient.
- This invention provides for a novel use, of soy molasses, a low cost material used almost exclusively as an inexpensive animal feed ingredient, for prevention and amelioration of divers and variant pathological conditions as well as to provide for general well-being.
- Soy molasses never before used or contemplated to be used, as such, as a composite for prevention and amelioration of divers and variant pathological conditions as well as to provide for general well-being, is an aggregate of various soybean phytochemical nutraceuticals as well as of soybean oligosugars.
- the purpose of this invention can be accomplished in various ways and modes as shall be hereinafter detailed. DETAILED DESCRIPTION OF THE INVENTION
- This invention is based on the discovery that the soy molasses, being a distinct composite source of the recognized benign soybean phytochemical nutraceuticals constituents: phytoestrogens such as the isoflavones genistein and daidzein, and other isoflavones, saponins, the low molecular weight protease inhibitor Birk-Bowman trypsin and chemotrypsin inhibitor, phytosterols, phytate, various lipids largely phospholipids, phenolic acids, et cetera, along with the soybean oligosugars stachyose and raffinose, can have a novel use for prevention and amelioration of divers and variant pathological conditions as well as to provide general well being, because of its special composition.
- phytoestrogens such as the isoflavones genistein and daidzein, and other isoflavones, saponins, the low molecular weight protease inhibitor Birk-Bowman
- soy molasses can be taken orally as a syrup or as a practically dried product, with or without various additives such as sweeteners, flavors, flavor masking agents, anti-caking agents, drug and physically active ingredients, anti foams, fillers, binders, preservatives, et cetera.
- the soy molasses having a typical sweet-bitter taste, can be taken orally in a capsule, a pill, a caplet, or a tablet form, with or without various additives or coatings.
- soy molasses can be used, for the purpose of this invention, as an inert or as a functional food ingredient, by adding and admixing the soy molasses to many and various processed food products, including baked products, for instance, baked "dark” or “brown” type breads, in which it also provides satisfactory brown color, characteristic sweet flavor and improved baking qualities, as well as providing benign soy nutraceutical constituents.
- the soy molasses can be used in a novel way as a composite source of the various phytochemical nutraceutical components as well as of the oligosugars of the soybean.
- This invention does not limit the lower or the upper daily intake levels of the soy molasses.
- Soybean products make foods that are generally regarded as safe and the soy molasses is basically a derived edible soy product. Even a small daily consumption of a few grams or less may prove useful. And though no upper limits have been ascertained, it would make a good sense to be cautious and not to exceed the daily intake beyond the amount that is well tolerated by the consuming individual.
- Dehydrated soy molasses made according to Israel Patent No. 19168, dried to 5 percent moisture, was encapsulated in gelatin capsules, containing 500 mg of dehydrated soy molasses per each capsule.
- the capsules given to be tried to volunteer individuals, were easily taken and ingested and no particular difficulties were noticed by individuals consuming one to two capsules, one to three times daily, for long periods of time exceeding several months.
- Baking tests were made with two standard white bread, straight-dough formulas, one as a control formula consisting of warm water, patent wheat flour, salt, sugar and yeast, and another one as a test formula with identical ingredients and quantities but with an addition of 4 percent soy molasses having 30% moisture.
- the dough was mixed on the firm side, fermented for 4 hours, divided, proofed for 15 minutes and baked for 35 minutes at 230°C. Both the control bread and the test bread were of satisfactory quality.
- the control bread was similar to a normal quality standard white bread.
- the test bread containing soy molasses had a typical sweet flavor and aroma and an agreeable brown color.
- test bread had a better volume, a smoother crust break, an even cell structure with smaller thin-walled cells and softer and velvety texture than the control bread.
- the test bread containing soy molasses was considered by an expert panel to have a better appearance and preferred eating qualities than the control bread.
- soy molasses as a composite of soybean nutraceuticals for prevention and amelioration of pathological conditions and for provision of well-being, without departing from the spirit of the invention, on condition that the fundamental principle of novel use of soy molasses, being a composite source of soybean phytochemical nutraceucicals in addition to soybean oligosugars, as set forth above is followed.
Abstract
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
AU66673/96A AU6667396A (en) | 1995-08-30 | 1996-08-07 | A novel use of soy molasses |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
IL11511095A IL115110A (en) | 1995-08-30 | 1995-08-30 | Soy molasses |
IL115110 | 1995-08-30 |
Publications (1)
Publication Number | Publication Date |
---|---|
WO1997007811A1 true WO1997007811A1 (fr) | 1997-03-06 |
Family
ID=11067931
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/IL1996/000076 WO1997007811A1 (fr) | 1995-08-30 | 1996-08-07 | Utilisation nouvelle de graines de soja |
Country Status (3)
Country | Link |
---|---|
AU (1) | AU6667396A (fr) |
IL (1) | IL115110A (fr) |
WO (1) | WO1997007811A1 (fr) |
Cited By (19)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2753050A1 (fr) * | 1996-08-21 | 1998-03-13 | Chajuss Daniel | Melasse de soja modifiee |
US5855892A (en) * | 1997-09-19 | 1999-01-05 | Potter; Susan M. | Method for decreasing LDL-cholesterol concentration and increasing HDL-cholesterol concentration in the blood to reduce the risk of atherosclerosis and vascular disease |
EP0906761A2 (fr) * | 1997-10-02 | 1999-04-07 | Archer-Daniels-Midland Company | Procédé de préparation et d'utilisation de produits phytochimiques |
US5919921A (en) * | 1996-06-11 | 1999-07-06 | Protein Technologies International, Inc. | Recovery of isoflavones from soy molasses |
US5952374A (en) * | 1997-09-29 | 1999-09-14 | Protein Technologies International, Inc. | Method for inhibiting the development of Alzheimer's disease and related dementias- and for preserving cognitive function |
US6015785A (en) * | 1996-04-12 | 2000-01-18 | Protein Technologies International, Inc. | Aglucone isofavone enriched vegetable protein extract and isolate and process for producing |
EP0993781A1 (fr) * | 1998-10-13 | 2000-04-19 | Societe Des Produits Nestle S.A. | Renforcement de la fonction immunitaire |
US6083553A (en) * | 1998-06-05 | 2000-07-04 | Protein Technologies International, Inc. | Recovery of isoflavones from soy molasses |
US6132795A (en) * | 1998-03-15 | 2000-10-17 | Protein Technologies International, Inc. | Vegetable protein composition containing an isoflavone depleted vegetable protein material with an isoflavone containing material |
EP1060744A1 (fr) * | 1998-03-06 | 2000-12-20 | Meijiseika Kaisha Ltd. | Agents pour prevenir/traiter l'osteoporose |
US6391310B1 (en) | 1996-03-13 | 2002-05-21 | Archer Daniels Midland Company | Method of preparing and using isoflavones for the treatment of neurological symptoms |
US6509043B1 (en) | 1998-11-25 | 2003-01-21 | Nutri Pharma Asa | Composition comprising soy protein, dietary fibres and a phytoestrogen compound and use thereof in the prevention and/or treatment of pulmonary diseases |
US6521282B1 (en) | 1996-08-09 | 2003-02-18 | Protein Technologies International, Inc. | Aglucone isoflavone enriched vegetable flour and grit |
US6544566B1 (en) | 1999-04-23 | 2003-04-08 | Protein Technologies International, Inc. | Composition containing plant sterol, soy protein and isoflavone for reducing LDL cholesterol |
US6579561B2 (en) | 1996-08-09 | 2003-06-17 | Protein Technologies International, Inc. | Aglucone isoflavone enriched vegetable flour and vegetable grit and process for making the same from a vegetable material containing isoflavone |
US6608111B1 (en) | 1998-06-23 | 2003-08-19 | Southern Illinois University Office Of Research, Development And Administration | Method for treating or preventing prostatic conditions |
US6630178B1 (en) | 1998-11-25 | 2003-10-07 | Nutri Pharma Asa | Composition comprising soy protein, dietary fibres and a phytoestrogen compound and use thereof in the prevention and/or treatment of cardiovascular diseases |
US6913771B2 (en) * | 2002-01-09 | 2005-07-05 | Oladur, Ltd | Process for the production of soybean sugars and the product produced thereof |
US7285297B1 (en) | 1999-04-23 | 2007-10-23 | Archer-Daniels-Midland Company | Method of reducing low density liproprotein cholesterol concentration |
Citations (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB831306A (en) * | 1955-01-13 | 1960-03-30 | British Soya Products Ltd | Improvements in processes for the production of baker's dough |
JPS6130593A (ja) * | 1984-07-20 | 1986-02-12 | Pelican:Kk | 大豆胚軸からのサポニン成分の抽出法 |
JPS6210018A (ja) * | 1985-07-04 | 1987-01-19 | Oruto Bioka Kenkyusho:Kk | 肥満抑制組成物 |
US4902673A (en) * | 1985-12-27 | 1990-02-20 | The Calpis Food Industry Co., Ltd. | Enhancing growth of bifidobacteria using soybean extract |
JPH02188598A (ja) * | 1989-01-17 | 1990-07-24 | Nippon Mektron Ltd | ソヤサポニンiの製造方法 |
JPH05170756A (ja) * | 1991-12-20 | 1993-07-09 | Kikkoman Corp | イソフラボン化合物の製造法 |
JPH06100583A (ja) * | 1992-09-22 | 1994-04-12 | Abo Sadakichi | 大豆サポニンの単離・精製方法および大豆サポニン |
-
1995
- 1995-08-30 IL IL11511095A patent/IL115110A/xx not_active IP Right Cessation
-
1996
- 1996-08-07 WO PCT/IL1996/000076 patent/WO1997007811A1/fr active Application Filing
- 1996-08-07 AU AU66673/96A patent/AU6667396A/en not_active Abandoned
Patent Citations (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB831306A (en) * | 1955-01-13 | 1960-03-30 | British Soya Products Ltd | Improvements in processes for the production of baker's dough |
JPS6130593A (ja) * | 1984-07-20 | 1986-02-12 | Pelican:Kk | 大豆胚軸からのサポニン成分の抽出法 |
JPS6210018A (ja) * | 1985-07-04 | 1987-01-19 | Oruto Bioka Kenkyusho:Kk | 肥満抑制組成物 |
US4902673A (en) * | 1985-12-27 | 1990-02-20 | The Calpis Food Industry Co., Ltd. | Enhancing growth of bifidobacteria using soybean extract |
JPH02188598A (ja) * | 1989-01-17 | 1990-07-24 | Nippon Mektron Ltd | ソヤサポニンiの製造方法 |
JPH05170756A (ja) * | 1991-12-20 | 1993-07-09 | Kikkoman Corp | イソフラボン化合物の製造法 |
JPH06100583A (ja) * | 1992-09-22 | 1994-04-12 | Abo Sadakichi | 大豆サポニンの単離・精製方法および大豆サポニン |
Non-Patent Citations (5)
Title |
---|
DATABASE WPI Section Ch Week 8613, Derwent World Patents Index; Class D13, AN 86-084456, XP002021316 * |
DATABASE WPI Section Ch Week 9035, Derwent World Patents Index; Class B03, AN 90-266223, XP002021317 * |
DATABASE WPI Section Ch Week 9332, Derwent World Patents Index; Class B03, AN 93-252721, XP002021314 * |
DATABASE WPI Section Ch Week 9419, Derwent World Patents Index; Class B03, AN 94-156649, XP002021315 * |
PATENT ABSTRACTS OF JAPAN vol. 011, no. 185 (C - 428) 13 June 1987 (1987-06-13) * |
Cited By (41)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6518319B1 (en) | 1996-03-13 | 2003-02-11 | Archer Daniels Midland Company | Method of preparing and using compositions extracted from vegetable matter for the treatment of female symptoms |
US6900240B2 (en) | 1996-03-13 | 2005-05-31 | Archer-Daniels-Midland Company | Method of preparing and using compositions extracted from vegetable matter for the treatment of cancer |
US6391309B1 (en) | 1996-03-13 | 2002-05-21 | Archer Daniesl Midland Company | Method of preparing and using isoflavones for the treatment of female symptoms |
US6391308B1 (en) | 1996-03-13 | 2002-05-21 | Archer Daniels Midland Company | Method of preparing and using isoflavones for the treatment of blood related illnesses |
US6395279B1 (en) | 1996-03-13 | 2002-05-28 | Archer Daniels Midland Company | Method of preparing and using isoflavones for the treatment of cancer |
US6391310B1 (en) | 1996-03-13 | 2002-05-21 | Archer Daniels Midland Company | Method of preparing and using isoflavones for the treatment of neurological symptoms |
US6261565B1 (en) | 1996-03-13 | 2001-07-17 | Archer Daniels Midland Company | Method of preparing and using isoflavones |
US6399072B1 (en) | 1996-03-13 | 2002-06-04 | Archer Daniels Midland Company | Method of preparing and using isoflavones for the treatment of alcoholism |
US6509381B2 (en) | 1996-03-13 | 2003-01-21 | Archer Daniels Midland Company | Method of preparing and using compositions extracted from vegetable matter for the treatment of neurological conditions |
US6015785A (en) * | 1996-04-12 | 2000-01-18 | Protein Technologies International, Inc. | Aglucone isofavone enriched vegetable protein extract and isolate and process for producing |
US6664382B2 (en) | 1996-06-11 | 2003-12-16 | Solae, Llc | Recovery of isoflavones from soy molasses |
US6495141B2 (en) | 1996-06-11 | 2002-12-17 | Protein Technologies International, Inc. | Recovery of isoflavones from soy molasses |
US5990291A (en) * | 1996-06-11 | 1999-11-23 | Protein Technologies International, Inc. | Recovery of isoflavones from soy molasses |
US6323018B1 (en) | 1996-06-11 | 2001-11-27 | Protein Technologies Int'l Lnc. | Recovery of isoflavones from soy molasses |
US5919921A (en) * | 1996-06-11 | 1999-07-06 | Protein Technologies International, Inc. | Recovery of isoflavones from soy molasses |
US6680381B1 (en) | 1996-06-11 | 2004-01-20 | Solae, Llc | Recovery of isoflavones from soy molasses |
US6706292B2 (en) | 1996-06-11 | 2004-03-16 | Solae, Llc | Recovery of isoflavones from soy molasses |
US6521282B1 (en) | 1996-08-09 | 2003-02-18 | Protein Technologies International, Inc. | Aglucone isoflavone enriched vegetable flour and grit |
US6579561B2 (en) | 1996-08-09 | 2003-06-17 | Protein Technologies International, Inc. | Aglucone isoflavone enriched vegetable flour and vegetable grit and process for making the same from a vegetable material containing isoflavone |
GB2317112B (en) * | 1996-08-21 | 2000-06-21 | Daniel Chajuss | Modified soy molasses |
GB2317112A (en) * | 1996-08-21 | 1998-03-18 | Daniel Chajuss | Modified soy molasses |
FR2753050A1 (fr) * | 1996-08-21 | 1998-03-13 | Chajuss Daniel | Melasse de soja modifiee |
US5855892A (en) * | 1997-09-19 | 1999-01-05 | Potter; Susan M. | Method for decreasing LDL-cholesterol concentration and increasing HDL-cholesterol concentration in the blood to reduce the risk of atherosclerosis and vascular disease |
US5952374A (en) * | 1997-09-29 | 1999-09-14 | Protein Technologies International, Inc. | Method for inhibiting the development of Alzheimer's disease and related dementias- and for preserving cognitive function |
EP0906761A3 (fr) * | 1997-10-02 | 1999-05-19 | Archer-Daniels-Midland Company | Procédé de préparation et d'utilisation de produits phytochimiques |
EP1466609A1 (fr) * | 1997-10-02 | 2004-10-13 | Archer-Daniels-Midland Company | Procédé de préparation et d'utilisation d'isoflavones |
EP0906761A2 (fr) * | 1997-10-02 | 1999-04-07 | Archer-Daniels-Midland Company | Procédé de préparation et d'utilisation de produits phytochimiques |
EP1060744A4 (fr) * | 1998-03-06 | 2004-03-17 | Meijiseika Kaisha Ltd | Agents pour prevenir/traiter l'osteoporose |
EP1060744A1 (fr) * | 1998-03-06 | 2000-12-20 | Meijiseika Kaisha Ltd. | Agents pour prevenir/traiter l'osteoporose |
US6132795A (en) * | 1998-03-15 | 2000-10-17 | Protein Technologies International, Inc. | Vegetable protein composition containing an isoflavone depleted vegetable protein material with an isoflavone containing material |
US6083553A (en) * | 1998-06-05 | 2000-07-04 | Protein Technologies International, Inc. | Recovery of isoflavones from soy molasses |
US6608111B1 (en) | 1998-06-23 | 2003-08-19 | Southern Illinois University Office Of Research, Development And Administration | Method for treating or preventing prostatic conditions |
EP0993781A1 (fr) * | 1998-10-13 | 2000-04-19 | Societe Des Produits Nestle S.A. | Renforcement de la fonction immunitaire |
US6630178B1 (en) | 1998-11-25 | 2003-10-07 | Nutri Pharma Asa | Composition comprising soy protein, dietary fibres and a phytoestrogen compound and use thereof in the prevention and/or treatment of cardiovascular diseases |
US6509043B1 (en) | 1998-11-25 | 2003-01-21 | Nutri Pharma Asa | Composition comprising soy protein, dietary fibres and a phytoestrogen compound and use thereof in the prevention and/or treatment of pulmonary diseases |
US6669952B2 (en) | 1999-04-23 | 2003-12-30 | Solae, Llc | Composition containing isoflavone material and plant sterol for reducing LDL-cholesterol |
US6579534B2 (en) | 1999-04-23 | 2003-06-17 | Solae, Llc | Composition containing soy hypocotyl material and plant sterol for reducing LDL-cholesterol |
US6572876B2 (en) | 1999-04-23 | 2003-06-03 | Solae, Llc | Administering a composition containing plant sterol, soy protein and isoflavone for reducing LDL-cholesterol |
US6544566B1 (en) | 1999-04-23 | 2003-04-08 | Protein Technologies International, Inc. | Composition containing plant sterol, soy protein and isoflavone for reducing LDL cholesterol |
US7285297B1 (en) | 1999-04-23 | 2007-10-23 | Archer-Daniels-Midland Company | Method of reducing low density liproprotein cholesterol concentration |
US6913771B2 (en) * | 2002-01-09 | 2005-07-05 | Oladur, Ltd | Process for the production of soybean sugars and the product produced thereof |
Also Published As
Publication number | Publication date |
---|---|
IL115110A0 (en) | 1995-12-08 |
IL115110A (en) | 1997-08-14 |
AU6667396A (en) | 1997-03-19 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
WO1997007811A1 (fr) | Utilisation nouvelle de graines de soja | |
Mishra et al. | Development of functional biscuit from soy flour & rice bran | |
Salazar et al. | Stevia rebaudiana: A sweetener and potential bioactive ingredient in the development of functional cookies | |
DE202009013228U1 (de) | Glutenfreie Nahrungsmittel | |
KR101249442B1 (ko) | 고초균을 이용한 빵의 제조방법 및 고초균에 의한 발효물을 포함하는 빵 | |
Szabłowska et al. | Acorn flour properties depending on the production method and laboratory baking test results: A review | |
JPH09502869A (ja) | 押し出し成形され予備湿潤処理されたオオバコを含有するインスタント・シリアル | |
Ghoshal et al. | Development of soymeal fortified cookies to combat malnutrition | |
Bhathal et al. | Quinoa-a treasure trove of nutrients | |
JPH09224606A (ja) | 発ガン予防物質を含有する健康飲食品 | |
KR101415143B1 (ko) | 곡물 과자 및 그 제조방법 | |
KR20200016153A (ko) | 식이섬유를 함유한 빵류 및 그 제조 방법 | |
KR100448841B1 (ko) | 발효 콩을 이용한 건강식품 | |
KR102580449B1 (ko) | 사과빵의 제조방법 및 이에 따라 제조된 사과빵 | |
Ranhotra et al. | Food uses of oats | |
KR102333231B1 (ko) | 산수유 쌀쿠키 및 이의 제조방법 | |
KR19980072453A (ko) | 상백피를 주성분으로 함유하는 당뇨환자용 과자류 조성물 | |
KR102569649B1 (ko) | 무설탕 가또쇼콜라의 제조방법 및 이에 따라 제조된 무설탕 가또쇼콜라 | |
EP1290952A1 (fr) | Compositions riches en fibres alimentaires | |
RU2277337C2 (ru) | Композиция для приготовления хлеба "тибет-праздничный" | |
CN109042797A (zh) | 一种薄荷味饼干及其制作方法 | |
Adhikari | Preparation, quality evaluation and shelf life study of dhule achar, A traditional pickle of nepal | |
KR20020033336A (ko) | 둥굴레 뿌리 추출물을 함유하는 식품 조성물 | |
Shahin et al. | Technological and Nutritional Evaluation of Biscuits Fortified Amaranths | |
KR102398679B1 (ko) | 가래떡 핫도그의 제조방법 및 이에 따라 제조된 가래떡 핫도그 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AK | Designated states |
Kind code of ref document: A1 Designated state(s): AL AM AT AU AZ BB BG BR BY CA CH CN CZ DE DK EE ES FI GB GE HU IS JP KE KG KP KR KZ LK LR LS LT LU LV MD MG MK MN MW MX NO NZ PL PT RO RU SD SE SG SI SK TJ TM TR TT UA UG US UZ VN AM AZ BY KG KZ MD RU TJ TM |
|
AL | Designated countries for regional patents |
Kind code of ref document: A1 Designated state(s): KE LS MW SD SZ UG AT BE CH DE DK ES FI FR GB GR IE IT LU MC NL PT SE BF BJ CF CG CI CM GA GN |
|
DFPE | Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101) | ||
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
REG | Reference to national code |
Ref country code: DE Ref legal event code: 8642 |
|
122 | Ep: pct application non-entry in european phase | ||
NENP | Non-entry into the national phase |
Ref country code: CA |